Goldman Sachs seems to be the only major bank implementing a start-to-finish AI-coding tool like Devin, but its competitors ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 10 ...

The arrival of agentic AI at Goldman Sachs, in which programs don’t just help with tasks but execute complex jobs, signals a ...

Despite dire forecasts and corporate hype, artificial intelligence (AI) has yet to deliver the sweeping job losses many ...

Devin won’t replace humans at the bank. Argenti advocates for a “hybrid” workforce, so instances of it will be supervised by ...

The number of AI-related jobs has grown in recent years, as more postings for AI engineers, GenAI consultants and other roles ...

Goldman Sachs tests AI engineer Devin, signaling a bold shift toward autonomous agents in high finance and software ...

Cognition is seeking to achieve a jaw-dropping $10B valuation as investors race to back the next big thing. Can its ...

In addition to the new funding, which saw participation from Japanese law firm Mori Hamada, the contract review and matter ...

"There is no sign of a significant impact on most labor market outcomes," chief economist Jan Hatzius writes. But the shift ...

The AI room really has some strong legs as we march through the peak of the summer season. And while investors should always ...

What the economy needs is a technological makeover, Goldman Sachs analysts wrote on Thursday.